ProHeart 6 Meeting Material Available

ProHeart 6 Meeting Material Available

The Food and Drug Administration has posted background information in advance of a meeting on the Risk Minimization Act Plan (RiskMAP) for Pfizer’s ProHeart 6.

The Veterinary Medicine Advisory Committee will meet March 24 to recommend modifications, if any, to the risk minimization and restricted distribution program for the injectable heartworm treatment. The panel will present FDA analysis of 18 months of data collected under the RiskMAP and will seek feedback from a panel of experts.

A voluntary recall was issued for ProHeart 6 in September 2004 to address federal safety concerns.

The background material is available here.

The committee will meet from 8:30 a.m. to 5 p.m. Wednesday, March 24, at the Rockville Hilton in Rockville, Md.

Oral presentations from the public are set for 1 to 2 p.m.

Leave a Comment


Your email address will not be published. Required fields are marked *


Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.